This #LungCancerAwarenessMonth, register for our extended eLearning course in biomarker-driven management of NSCLC. 📢 Join our case-based webinar on November 11 to hear expert perspectives on the latest in NTRK fusion-positive NSCLC. Register now: https://t.co/NXvVVIj2Bs

Explore this simulation-based module, bringing shared decision-making to life in the context of biomarker use in Alzheimer’s disease. Dr Chuck Vega demonstrates the key principles of SDM alongside his mother, drawing on their family’s experience with AD: https://t.co/8iLdruGtmk

Looking for key updates on NTRK fusion-positive NSCLC? Join our experts on Tuesday 11 November, as they discuss the latest developments in the disease, including new data and recommendations presented at #ESMO25. Secure your place for free today: https://t.co/sPr2cbFhLG

As #ESMO2025 draws to a close, continue your learning on targeted therapies with the AML Expert Series. Hosted by @Dr_AmerZeidan of @YaleCancer, this podcast series is designed to enhance your knowledge of IDH-mutant R/R AML. Tune in now: https://t.co/6bKiMMJiuA

Do you manage patients with generalized myasthenia gravis? Access this expert-led program, complete with CME-accredited video podcasts and downloadable resources, designed to help you improve your patient care: https://t.co/ZwIVe1A4ND #gMG #GeneralizedMyastheniaGravis

Are you looking for key updates on NTRK fusion-positive NSCLC? Our experts discuss the latest updates, including their perspectives on detection, treatment, and real-world challenges in this live webinar, including updates from ESMO 2025: https://t.co/hL2qsYqCJ2

IBAT inhibitor case studies point to adult intrahepatic cholestasis benefits. Read the full news story on our program ‘Unveiling the spectrum: A deep dive into late-onset genetic cholestasis’ Read now https://t.co/B7v0fW6AZa

We’re at #EASD2025 talking about our new Ketones Monitoring Masterclass, and we’d love to hear your thoughts on the topic. What aspect of ketone monitoring in diabetes care interests you most right now? To learn more, visit our CME-accredited program:

Deepen your understanding of DKA pathophysiology with expert insights into metabolic mechanisms and risk factors - featuring an engaging animated visual explainer. Start the masterclass today and earn free CME credit https://t.co/iIkqUlT71b #DKA #pathophysiology #MedEd #CME

With EASD coming up, stay ahead in ketone monitoring! Join Dr. David Kerr in our CME-accredited Ketone Monitoring Masterclass and explore CKM’s role in DKA prevention. Get ahead! Register and earn CME https://t.co/piX9jRutin #EASD2025 #DiabetesCare #DKA #KetoneMonitoring #CME

Refine your DKA diagnostic approach with expert-led guidance on applying the latest evidence and clinical criteria. Featuring a real-world case study. Sharpen your skills! Start this free accredited masterclass now. https://t.co/iXefql3NnU #DKA #CME #diabetesmanagement #MedEd

In Episode 3, hosted by @ProfAmerZeidan, take a focused look at IDH1-mutant R/R AML. Learn how IDH inhibitors work, review pivotal trial data, and hear expert perspectives on safety, efficacy, and clinical impact. AML Expert Series, Ep 3 – Tune in now! https://t.co/kqtDcn02xI

Episode 2 of The AML Expert Series explores the evolving role of targeted therapies in R/R AML. Discover evidence-based strategies, current regimens, & key guideline updates to inform your practice. AML Expert Series, Ep 2 – Tune in now! https://t.co/XPmSrwxiyK #oncology #AML

Just launched! Access expert-led insights on DKA guidelines, pathophysiology, emerging technologies, and practical strategies to overcome real-world barriers. Register now and earn free CME credit https://t.co/yz5WkveAjh

How can molecular testing be better integrated into AML care? In Episode 1 of The AML Expert Series, hear practical strategies to overcome barriers & apply testing insights to optimize patient outcomes. AML Expert Series, Ep 1 – Tune in now!  https://t.co/GWWHmu04Of #AML #meded

Now live: The AML Expert Series - a 3-part podcast on molecular testing, IDH1/2 mutations, targeted therapies and personalized strategies in R/R AML - hosted by @ProfAmerZeidan with leading experts. Advance your practice in R/R AML – https://t.co/HlS8pGWpui #oncology #meded

Access expert guidance on diagnosing and treating late-onset genetic cholestasis, with this interactive clinical pathway tool. Access here https://t.co/KGZ8YeaEPv #LiverDisease #Hepatology #Gastroenterology

How well do you know CAR-T therapy for DLBCL? Following #EHA2025, we're putting your clinical insight to the test. You can find key updates and highlights at: https://t.co/JoPXWkwSKO What’s the biggest barrier to wider CAR-T use in DLBCL?

Elevate patient care in aplastic anemia with individualized treatment strategies. Our latest module is designed to help you tailor management for special populations, through real-world scenarios and expert-led insights. Get started here https://t.co/z4bhL985E4 #aplasticanemia

Just launched! The AML expert series - a 3-part podcast series featuring expert insights on molecular testing, key genetic mutations, such as IDH1/2, targeted therapies, and personalized treatment strategies. Advance your practice in R/R AML – listen now https://t.co/6OVbVbysZG